1. Home
  2. BNTC vs SKYH Comparison

BNTC vs SKYH Comparison

Compare BNTC & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • SKYH
  • Stock Information
  • Founded
  • BNTC 1995
  • SKYH 2017
  • Country
  • BNTC United States
  • SKYH United States
  • Employees
  • BNTC N/A
  • SKYH N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • SKYH Military/Government/Technical
  • Sector
  • BNTC Health Care
  • SKYH Industrials
  • Exchange
  • BNTC Nasdaq
  • SKYH Nasdaq
  • Market Cap
  • BNTC 365.1M
  • SKYH 343.5M
  • IPO Year
  • BNTC N/A
  • SKYH N/A
  • Fundamental
  • Price
  • BNTC $16.61
  • SKYH $10.40
  • Analyst Decision
  • BNTC Strong Buy
  • SKYH Strong Buy
  • Analyst Count
  • BNTC 5
  • SKYH 2
  • Target Price
  • BNTC $24.80
  • SKYH $14.25
  • AVG Volume (30 Days)
  • BNTC 63.1K
  • SKYH 108.4K
  • Earning Date
  • BNTC 11-13-2025
  • SKYH 11-11-2025
  • Dividend Yield
  • BNTC N/A
  • SKYH N/A
  • EPS Growth
  • BNTC N/A
  • SKYH N/A
  • EPS
  • BNTC N/A
  • SKYH N/A
  • Revenue
  • BNTC N/A
  • SKYH $20,919,000.00
  • Revenue This Year
  • BNTC N/A
  • SKYH $118.09
  • Revenue Next Year
  • BNTC N/A
  • SKYH $88.34
  • P/E Ratio
  • BNTC N/A
  • SKYH N/A
  • Revenue Growth
  • BNTC N/A
  • SKYH 94.38
  • 52 Week Low
  • BNTC $9.10
  • SKYH $9.28
  • 52 Week High
  • BNTC $17.15
  • SKYH $14.52
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 72.99
  • SKYH 55.13
  • Support Level
  • BNTC $15.18
  • SKYH $9.90
  • Resistance Level
  • BNTC $16.62
  • SKYH $10.29
  • Average True Range (ATR)
  • BNTC 0.69
  • SKYH 0.40
  • MACD
  • BNTC 0.13
  • SKYH 0.03
  • Stochastic Oscillator
  • BNTC 99.67
  • SKYH 55.20

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

Share on Social Networks: